Recent News News Blog Press Releases In the News Featured News Publications Contact Us Blog Post Sep. 22, 2022 Supporting Science Across Borders with Student Exchange In 2020, The Wistar Institute kickstarted a Ph.D. exchange program with the University of Bologna for budding scientists in cell and molecular biology. Exchange students travel to Philadelphia and… Blog Post Sep. 20, 2022 Finding Balance at the Bench This National Postdoc Appreciation Week, we asked our postdoctoral fellows how they strive to keep balance between their research and personal lives. Blog Post Sep. 19, 2022 Setting a Prime Example: Wistar’s Women & Science Program feat... As attendees tuned into their screens, Dr. Elizabeth Jaffee began her presentation Pancreatic Cancer Is PRIMED to Become an Immunologic Disease. Press Release Sep. 19, 2022 Wistar Scientists Identify Key Biomarkers that Reliably Predict Re... New research finds biological processes that improve prediction of therapeutic performance and provide a framework to develop predictors for this aggressive skin cancer. Blog Post Sep. 16, 2022 Unraveling The Enigmas of Melanoma Meenhard Herlyn, D.V.M., D.Sc., is known internationally as one of the fathers of melanoma research. Now, a new generation of melanoma researchers are building on that… Blog Post Sep. 13, 2022 Unraveling the Ties That Bind: Epstein-Barr Virus and Multiple Scl... A conversation with the Lieberman Lab delves into how EBV can trigger MS and potential therapeutic solutions that can be developed with this … Featured News Sep. 12, 2022 Exceptional Wistar Trainees Honored at 2022 Rugart Family Awards C... Dr. Laura Garcia Gerique, postdoctoral fellow in the Nefedova lab, and Sarah Offley, graduate student in Gardini lab, are winners of the 2022 Annual Rugart Family Awards. Featured News Sep. 9, 2022 Wistar Scientists Find Gut Microbe Byproduct Drives Antitumor Immu... The team identified the metabolite TMAO drives immune activation in the tumor microenvironment and boosts response to immune checkpoint blockade therapy in pancreatic … Press Release Sep. 8, 2022 The Wistar Institute Welcomes Michele A. Schiavoni, New Vice Presi... Wistar is pleased to announce the appointment of Michele A. Schiavoni, M.S., as Vice President of Communications & Marketing. Press Release Sep. 7, 2022 The Wistar Institute and Jubilant Therapeutics Inc. Find PAD4 Inhi... Novel PAD4 inhibitor reduces primary tumor, metastases and enhances checkpoint inhibitor treatments. Blog Post Sep. 6, 2022 Advancing Scientific Enterprise at Wistar’s Vaccine and Immunother... With just over a year at The Wistar Institute under their respective scientific belts, innovator-scientists Amelia Escolano, Ph.D., and Daniel Claiborne, Ph.D., have been pushing the scientific… Blog Post Sep. 1, 2022 Scientists Drive Innovation at Wistar’s Ellen and Ronald Caplan Ca... Wistar continues to be a dynamic environment prepared to tackle biomedical challenges in a collaborative, innovative, and inclusive culture. Communications In the News Check out some of the recent media coverage Wistar and its scientists have received. Publications View our Annual Report, Focus magazine and sign-up for our monthly e-newsletter. Media Inquiries If you are a member of the media and would like to speak with a Wistar scientists on any matter, please contact our Communications and Marketing Department. Partnership Seal
